Preoperative serum sodium is associated with cancer-specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy.

MLA

Fujita, Kazutoshi, et al. “Preoperative Serum Sodium Is Associated with Cancer-Specific Survival in Patients with Upper Urinary Tract Urothelial Carcinoma Treated by Nephroureterectomy.” International Journal of Urology : Official Journal of the Japanese Urological Association, vol. 20, no. 6, June 2013, pp. 594–601. EBSCOhost, https://doi.org/10.1111/j.1442-2042.2012.03228.x.

APA

Fujita, K., Tanigawa, G., Imamura, R., Nakagawa, M., Hayashi, T., Kishimoto, N., Hosomi, M., & Yamaguchi, S. (2013). Preoperative serum sodium is associated with cancer-specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy. International Journal of Urology : Official Journal of the Japanese Urological Association, 20(6), 594–601. https://doi.org/10.1111/j.1442-2042.2012.03228.x

Chicago

Fujita, Kazutoshi, Go Tanigawa, Ryoichi Imamura, Masahiro Nakagawa, Takuji Hayashi, Nozomu Kishimoto, Masahiro Hosomi, and Seiji Yamaguchi. 2013. “Preoperative Serum Sodium Is Associated with Cancer-Specific Survival in Patients with Upper Urinary Tract Urothelial Carcinoma Treated by Nephroureterectomy.” International Journal of Urology : Official Journal of the Japanese Urological Association 20 (6): 594–601. doi:10.1111/j.1442-2042.2012.03228.x.